查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1682070

2025年臨床次世代定序（NGS）資料分析全球市場報告

Clinical Next-Generation Sequencing (NGS) Data Analysis Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年臨床次世代定序（NGS）資料分析市場規模將呈指數級成長。到 2029 年，這一數字將成長至 87.3 億美元，複合年成長率為 20.5%。預測期內的成長可歸因於液態切片技術的日益普及、人工智慧在資料分析中的整合、精準醫療計劃的擴大、新型定序技術的出現以及對群體基因組學計劃的日益關注。預測期內的關鍵趨勢包括伴同性診斷的成長、分散式檢查模型的興起、雲端基礎的解決方案的使用增加、NGS 在非侵入性產前檢測中的應用擴大以及資料解釋標準化通訊協定的開發。

在個人化醫療需求不斷成長的推動下，臨床下一代定序資料分析市場預計將成長。個人化醫療是根據個人的遺傳、環境和生活方式因素量身定做的，由於基因組技術、疾病複雜性的增加、治療效果的改善以及醫療成本的上升而受到關注。次世代定序(NGS)資料分析在個人化醫療中發揮關鍵作用，有助於快速且準確地對多個基因定序，從而提高對個別基因圖譜的了解。例如，2022年10月的資料顯示，基因檢測產品和個人化藥物數量顯著增加，其中個人化藥物在新藥認證中佔比顯著上升，這表明NGS資料分析在推動個人化醫療的採用方面發揮著至關重要的作用。

臨床 NGS資料分析市場的主要企業正在進行創新，以滿足對基因組分析準確性日益成長的需求。 NextSeq 2000定序系統等先進的解決方案代表了該領域的重要發展。該系統由整合的硬體和軟體組件組成，旨在簡化 DNA定序過程，提供 DNA 分子內的精確核苷酸定序。例如，Illumina Inc. 於 2022 年 9 月發布的 NovaSeq X 系列代表了生產規模定序的模式轉移，具有更高的速度、功率和永續性。 NovaSeq X 系列利用 XLEAP-SBS 化學和超高密度流動槽等創新技術，顯著提高了吞吐量和定序準確性，以滿足日益成長的基因組分析需求。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場－宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情以及復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球臨床次世代定序 (NGS)資料分析 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素、限制因素）
  • 最終用途產業分析
  • 全球臨床次世代定序（NGS）資料分析市場：成長率分析
  • 全球臨床次世代定序 (NGS)資料分析市場表現：規模與成長，2019-2024 年
  • 全球臨床次世代定序 (NGS)資料分析市場預測：規模與成長，2024-2029 年，2034 年
  • 全球臨床次世代定序（NGS）資料分析總目標市場（TAM）

第6章市場區隔

  • 全球臨床次世代定序 (NGS)資料分析市場（按解決方案和服務、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • NGS資料分析工具
  • NGS資料分析與定序服務
  • NGS儲存、管理與雲端運算平台
  • 平台
  • 全球臨床次世代定序 (NGS)資料分析市場（按技術、效能和預測）：2019-2024 年、2024-2029 年、2034 年
  • 邊定序序（SBS）
  • 奈米孔定序
  • 單分子即時（SMRT）定序
  • 其他技術
  • 全球臨床次世代定序 (NGS)資料分析市場的應用、效能和預測（2019-2024 年、2024-2029 年及 2034 年）
  • 診斷
  • 藥物發現與設計
  • 醫學研究
  • 其他用途
  • 全球臨床次世代定序 (NGS)資料分析市場（按最終用戶、效能和預測）2019-2024 年、2024-2029 年、2034 年
  • 醫院和診所
  • 學術機構與研究中心
  • 生技公司
  • 生命科學技術供應商
  • 其他最終用戶
  • 全球臨床次世代定序 (NGS)資料分析市場細分（按 NGS資料分析工具類型、效能和預測），2019-2024 年、2024-2029 年、2034 年
  • 軟體平台
  • 資料解釋工具
  • 生物資訊學工具
  • 資料分析解決方案
  • 全球臨床次世代定序 (NGS)資料分析市場 NGS資料分析和定序服務細分（按類型）、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 定序服務
  • 資料分析服務
  • 諮詢服務
  • 研究和診斷服務
  • 全球臨床次世代定序 (NGS)資料分析市場區隔（按 NGS 儲存、管理和雲端運算平台類型分類）、實際情況和預測（2019-2024 年、2024-2029 年、2034 年）
  • 資料儲存解決方案
  • 資料管理平台
  • 雲端基礎的平台
  • 雲端儲存服務
  • 全球臨床次世代定序 (NGS)資料分析市場細分（按平台、類型、效能和預測），2019-2024 年、2024-2029 年、2034 年
  • 定序平台
  • NGS測量平台
  • 整合NGS平台

第7章 區域和國家分析

  • 全球臨床次世代定序 (NGS)資料分析市場：按地區、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 全球臨床次世代定序 (NGS)資料分析市場：按國家/地區、績效和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 臨床次世代定序（NGS）資料分析市場：競爭格局
  • 臨床次世代定序（NGS）資料分析市場：公司簡介
    • Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • PerkinElmer Inc.
  • Bio-Rad Laboratories Inc.
  • Qiagen
  • BGI Group
  • 10x Genomics
  • Genomic Health
  • Oxford Nanopore Technologies PLC
  • Pacific Biosciences of California Inc.
  • Sophia Genetics
  • Genewiz
  • Partek Inc.
  • DNAnexus
  • BioNano Genomics
  • PierianDx
  • GENAPSYS

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年臨床次世代定序（NGS）資料分析市場：提供新機會的國家
  • 2029年臨床次世代定序（NGS）資料分析市場：細分市場帶來新機會
  • 2029年臨床次世代定序（NGS）資料分析市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r27676

Clinical next-generation sequencing (NGS) data analysis is the interpretation of genetic information acquired through advanced sequencing technologies within a clinical context. These technologies enable the rapid and cost-effective sequencing of large DNA or RNA samples, allowing for the identification of genetic variations associated with diseases or conditions. This analytical process is essential for comprehending the genetic underpinnings of diseases, supporting personalized medicine approaches, and guiding clinical decision-making.

The main types of solutions and services in clinical next-generation sequencing (NGS) data analysis encompass NGS data analysis tools, NGS data analysis and sequencing services, and NGS storage, management, and cloud computing platforms. NGS data analysis tools are software applications designed to interpret and process the vast amount of data generated through NGS technologies. Leveraging various sequencing technologies such as sequencing by synthesis (SBS), nanopore sequencing, and single-molecule real-time (SMRT) sequencing, these tools find applications in diagnostics, drug discovery, medical research, and other domains. End-users of these tools span hospitals, clinics, academic institutes, research centers, biotechnology companies, and life science technology vendors.

The clinical next-generation sequencing (NGS) data analysis market research report is one of a series of new reports from The Business Research Company that provides clinical next-generation sequencing (NGS) data analysis market statistics, including clinical next-generation sequencing (NGS) data analysis industry global market size, regional shares, competitors with a clinical next-generation sequencing (NGS) data analysis market share, detailed clinical next-generation sequencing (NGS) data analysis market segments, market trends and opportunities, and any further data you may need to thrive in the clinical next-generation sequencing (NGS) data analysis industry. This clinical next-generation sequencing (NGS) data analysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The clinical next-generation sequencing (NGS) data analysis market size has grown exponentially in recent years. It will grow from $3.43 billion in 2024 to $4.15 billion in 2025 at a compound annual growth rate (CAGR) of 20.8%. The growth in the historic period can be attributed to research advancements in genomics, declining sequencing costs, growing demand for personalized medicine, expanding applications in clinical diagnostics, increasing prevalence of genetic diseases.

The clinical next-generation sequencing (NGS) data analysis market size is expected to see exponential growth in the next few years. It will grow to $8.73 billion in 2029 at a compound annual growth rate (CAGR) of 20.5%. The growth in the forecast period can be attributed to rising adoption of liquid biopsy techniques, integration of artificial intelligence in data analysis, expansion of precision medicine initiatives, emergence of novel sequencing technologies, increasing focus on population genomics initiatives. Major trends in the forecast period include growth of companion diagnostics, rise of decentralized testing models, increasing use of cloud-based solutions, expansion of NGS applications in non-invasive prenatal testing, development of standardized protocols for data interpretation.

The clinical next-generation sequencing data analysis market is poised for growth, propelled by the rising demand for personalized medicines. Personalized medicine, tailored to individual genetic, environmental, and lifestyle factors, gains prominence due to genomic technologies, increasing disease complexity, improved treatment outcomes, and escalating healthcare costs. Next-generation sequencing (NGS) data analysis plays a pivotal role in personalized medicine, facilitating rapid and accurate sequencing of multiple genes, thereby enhancing understanding of an individual's genetic profile. For example, data from October 2022 reports a significant number of genetic testing products and personalized medicines, with personalized medicines accounting for a notable portion of new drug approvals, underlining the integral role of NGS data analysis in driving personalized medicine adoption.

Key players in the clinical NGS data analysis market are innovating to meet burgeoning demands for genomic analysis accuracy. Advanced solutions such as the NextSeq 2000 Sequencing System represent significant developments in this realm. This system comprises integrated hardware and software components designed to streamline DNA sequencing processes, offering precise nucleotide sequencing within DNA molecules. For instance, Illumina Inc.'s September 2022 launch of the NovaSeq X Series introduces a paradigm shift in production-scale sequencing, boasting enhanced speed, power, and sustainability. Leveraging innovative technology such as XLEAP-SBS chemistry and ultra-high density flow cells, the NovaSeq X Series offers substantially increased throughput and sequencing accuracy, meeting the escalating demands for genomic analysis.

In January 2023, QIAGEN NV, a Germany-based provider of molecular testing solutions, acquired Verogen Inc. for $150 million. The acquisition aims to strengthen QIAGEN's molecular testing and forensic genomics offerings by incorporating Verogen's next-generation sequencing (NGS) technology, which enhances capabilities in genetic analysis. Verogen Inc., a US-based company, specializes in NGS solutions focused on human identification (Human ID) and forensic applications.

Major companies operating in the clinical next-generation sequencing (NGS) data analysis market are Roche Diagnostics, Thermo Fisher Scientific Inc., Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen, BGI Group, 10x Genomics, Genomic Health, Oxford Nanopore Technologies PLC., Pacific Biosciences of California Inc., Sophia Genetics, Genewiz, Partek Inc., DNAnexus, BioNano Genomics, PierianDx, GENAPSYS, Nugen Technologies, DNAStar Inc., Swift Biosciences, Basepair, BioDatomics, Congenica Ltd., Theragen Etex Inc., Golden Helix Inc.

North America was the largest region in the clinical next-generation sequencing (NGS) data analysis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical next-generation sequencing (NGS) data analysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the clinical next-generation sequencing (NGS) data analysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The clinical next-generation sequencing data analysis market consists of revenues earned by entities by providing services such as data preprocessing, alignment, variable calling, annotation, prioritization, interpretation, and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical next-generation sequencing data analysis market also includes sales of software tools, platforms, and pre-processing tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Clinical Next-Generation Sequencing (NGS) Data Analysis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on clinical next-generation sequencing (ngs) data analysis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for clinical next-generation sequencing (ngs) data analysis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The clinical next-generation sequencing (ngs) data analysis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Solution And Services: NGS Data Analysis Tools; NGS Data Analysis And Sequencing Services; NGS Storage, Management And Cloud Computing Platform; Platforms
  • 2) By Technology: Sequencing By Synthesis (SBS); Nanopore Sequencing; Single-Molecule Real-Time (SMRT) Sequencing; Other Technologies
  • 3) By Application: Diagnostics; Drug Discovery And Designing; Medical Research; Other Applications
  • 4) By End User: Hospitals And Clinics; Academic Institutes And Research Centers; Biotechnology Companies; Life Science Technology Vendors; Other End Users
  • Subsegments:
  • 1) By NGS Data Analysis Tools: Software Platforms; Data Interpretation Tools; Bioinformatics Tools; Data Analytics Solutions
  • 2) By NGS Data Analysis And Sequencing Services: Sequencing Services; Data Analysis Services; Consultation Services; Research And Diagnostic Services
  • 3) By NGS Storage, Management, And Cloud Computing Platform: Data Storage Solutions; Data Management Platforms; Cloud-Based Platforms; Cloud Storage Services
  • 4) By Platforms: Sequencing Platforms; NGS Instrumentation Platforms; Integrated NGS Platforms
  • Companies Mentioned: Roche Diagnostics; Thermo Fisher Scientific Inc.; Eurofins Scientific; Agilent Technologies Inc.; Illumina Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Characteristics

3. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Trends And Strategies

4. Clinical Next-Generation Sequencing (NGS) Data Analysis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Clinical Next-Generation Sequencing (NGS) Data Analysis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market Growth Rate Analysis
  • 5.4. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Total Addressable Market (TAM)

6. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Segmentation

  • 6.1. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • NGS Data Analysis Tools
  • NGS Data Analysis And Sequencing Services
  • NGS Storage, Management And Cloud Computing Platform
  • Platforms
  • 6.2. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencing By Synthesis (SBS)
  • Nanopore Sequencing
  • Single-Molecule Real-Time (SMRT) Sequencing
  • Other Technologies
  • 6.3. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostics
  • Drug Discovery And Designing
  • Medical Research
  • Other Applications
  • 6.4. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Academic Institutes And Research Centers
  • Biotechnology Companies
  • Life Science Technology Vendors
  • Other End Users
  • 6.5. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Sub-Segmentation Of NGS Data Analysis Tools, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software Platforms
  • Data Interpretation Tools
  • Bioinformatics Tools
  • Data Analytics Solutions
  • 6.6. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Sub-Segmentation Of NGS Data Analysis And Sequencing Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencing Services
  • Data Analysis Services
  • Consultation Services
  • Research And Diagnostic Services
  • 6.7. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Sub-Segmentation Of NGS Storage, Management, And Cloud Computing Platform, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Data Storage Solutions
  • Data Management Platforms
  • Cloud-Based Platforms
  • Cloud Storage Services
  • 6.8. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Sub-Segmentation Of Platforms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencing Platforms
  • NGS Instrumentation Platforms
  • Integrated NGS Platforms

7. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Regional And Country Analysis

  • 7.1. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 8.1. Asia-Pacific Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 9.1. China Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 9.2. China Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 10.1. India Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 11.1. Japan Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 11.2. Japan Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 12.1. Australia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 13.1. Indonesia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 14.1. South Korea Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 14.2. South Korea Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 15.1. Western Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 15.2. Western Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 16.1. UK Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 17.1. Germany Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 18.1. France Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 19.1. Italy Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 20.1. Spain Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 21.1. Eastern Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 21.2. Eastern Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 22.1. Russia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 23.1. North America Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 23.2. North America Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 24.1. USA Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 24.2. USA Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 25.1. Canada Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 25.2. Canada Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 26.1. South America Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 26.2. South America Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 27.1. Brazil Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 28.1. Middle East Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 28.2. Middle East Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 29.1. Africa Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 29.2. Africa Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Competitive Landscape And Company Profiles

  • 30.1. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Competitive Landscape
  • 30.2. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Company Profiles
    • 30.2.1. Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Other Major And Innovative Companies

  • 31.1. PerkinElmer Inc.
  • 31.2. Bio-Rad Laboratories Inc.
  • 31.3. Qiagen
  • 31.4. BGI Group
  • 31.5. 10x Genomics
  • 31.6. Genomic Health
  • 31.7. Oxford Nanopore Technologies PLC
  • 31.8. Pacific Biosciences of California Inc.
  • 31.9. Sophia Genetics
  • 31.10. Genewiz
  • 31.11. Partek Inc.
  • 31.12. DNAnexus
  • 31.13. BioNano Genomics
  • 31.14. PierianDx
  • 31.15. GENAPSYS

32. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Clinical Next-Generation Sequencing (NGS) Data Analysis Market

34. Recent Developments In The Clinical Next-Generation Sequencing (NGS) Data Analysis Market

35. Clinical Next-Generation Sequencing (NGS) Data Analysis Market High Potential Countries, Segments and Strategies

  • 35.1 Clinical Next-Generation Sequencing (NGS) Data Analysis Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Clinical Next-Generation Sequencing (NGS) Data Analysis Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Clinical Next-Generation Sequencing (NGS) Data Analysis Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer